Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Genet Mol Res ; 13(4): 10301-7, 2014 Dec 04.
Artigo em Inglês | MEDLINE | ID: mdl-25501242

RESUMO

The aim of this study was to evaluate myeloid expression in acute lymphoblastic leukemia (ALL) in children and adolescents who had been referred to the Oncology Department in a hospital in the State of Maranhão based on demographic, laboratory, and clinical data. Myeloid expression was evaluated in 65 patients under 18 years of age who were diagnosed with morphological, cytochemical, and immunophenotypes of ALL. Demographic, laboratory (hemogram), and clinical variables were obtained from medical records. The sample was divided into groups with and without anomalous myeloid expression to analyze the variables. Myeloid expression was observed in 49.2% of the sample. Platelet count was significantly lower in the group of children without aberrant myeloid expression (33,627 platelets/mm(3), P = 0.01). A total of 88.9% of children with B-cell ALL without myeloid expression showed less than 50,000 platelets/mm(3) (P = 0.01). Thus, platelet count may be an important parameter in the diagnosis of children with ALL without myeloid aberrant expression and may indicate a greater risk of bleeding during treatment in this group.


Assuntos
Linfócitos B/imunologia , Células Mieloides/patologia , Leucemia-Linfoma Linfoblástico de Células Precursoras B/genética , Leucemia-Linfoma Linfoblástico de Células T Precursoras/genética , Adolescente , Linfócitos B/patologia , Brasil , Antígenos CD13/biossíntese , Antígenos CD13/imunologia , Criança , Pré-Escolar , Feminino , Citometria de Fluxo , Regulação Leucêmica da Expressão Gênica , Humanos , Imunofenotipagem , Masculino , Células Mieloides/metabolismo , Contagem de Plaquetas , Leucemia-Linfoma Linfoblástico de Células Precursoras B/imunologia , Leucemia-Linfoma Linfoblástico de Células Precursoras B/patologia , Leucemia-Linfoma Linfoblástico de Células T Precursoras/imunologia , Leucemia-Linfoma Linfoblástico de Células T Precursoras/patologia , Prognóstico , Lectina 3 Semelhante a Ig de Ligação ao Ácido Siálico/biossíntese , Lectina 3 Semelhante a Ig de Ligação ao Ácido Siálico/imunologia
2.
J Mol Neurosci ; 46(1): 58-67, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21870155

RESUMO

Opioid peptides play a key role in ethanol reinforcement and alcohol drinking behavior. However, regulation of opioid levels by peptidase-degrading activities in ethanol's actions in brain is still unclear. The aim of this work was to study the acute effects of ethanol (2.5 g/kg) on enkephalinase (NEP) and aminopeptidase N (APN) activities and expression in regions of the mesocorticolimbic system, as well as on corticosterone levels in serum for up to 24 h after administration. Enzymatic activities were measured by fluorometric assays, mRNA's expression by reverse transcriptase polymerase chain reaction (RT-PCR) and corticosterone levels by radioimmunoassay. Acute ethanol administration modified peptidase activity and expression with different kinetics. Ethanol induced a transitory increase and decrease in NEP and APN activities in the frontal cortex (FC) and ventral tegmental area (VTA), whereas only increases in these activities were observed in the nucleus accumbens (NAcc). Ethanol induced an increase in NEP mRNA in the FC and decreases in APN mRNA in the FC and NAcc. In contrast, ethanol produced biphasic effects on both enzymes expression in the VTA. Corticosterone levels were not changed by ethanol. Our results suggest that NEP and APN could play a main role in ethanol reinforcement through regulation of opioid levels in mesolimbic areas.


Assuntos
Consumo de Bebidas Alcoólicas/metabolismo , Transtornos do Sistema Nervoso Induzidos por Álcool/metabolismo , Antígenos CD13/genética , Etanol/toxicidade , Sistema Límbico/enzimologia , Neprilisina/genética , Área Tegmentar Ventral/enzimologia , Doença Aguda , Animais , Antígenos CD13/biossíntese , Sistema Límbico/efeitos dos fármacos , Masculino , Neprilisina/biossíntese , Ratos , Ratos Wistar , Área Tegmentar Ventral/efeitos dos fármacos
3.
Leuk Res ; 32(2): 211-3, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17675154

RESUMO

Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated with disease progression in myelodysplastic syndromes (MDS). We analyzed the influence on overall survival of the expression of lineage and maturation-associated antigens of BM hemopoietic cells quantified in a previous study. In the univariate Cox regression the peripheral platelet count was a significant favourable factor for overall survival. Unfavorable prognostic factors were: WPSS, increase in BM CD34+ cells, increased mean fluorescence intensity (MFI) of CD13 on myelocytes, metamyelocytes and mature neutrophils as well as increased CD45 of myelocytes and mature neutrophils. In a model containing platelet count, WPSS and MFI of CD45 and CD13 on mature neutrophils, only hyperexpression of CD13 and degree of thrombocytopenia were independent risk factors. Therefore, phenotypic features that can also be obtained from PB might be useful for predicting survival in MDS.


Assuntos
Biomarcadores Tumorais/análise , Células da Medula Óssea/patologia , Células-Tronco Hematopoéticas/patologia , Síndromes Mielodisplásicas/patologia , Fenótipo , Contagem de Plaquetas , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígenos CD34/biossíntese , Células da Medula Óssea/metabolismo , Antígenos CD13/biossíntese , Linhagem da Célula , Citometria de Fluxo , Células-Tronco Hematopoéticas/metabolismo , Humanos , Imunofenotipagem , Antígenos Comuns de Leucócito/biossíntese , Pessoa de Meia-Idade , Prognóstico
4.
Am J Hematol ; 76(1): 44-51, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15114596

RESUMO

Acute promyelocytic leukemia (APL) is a subtype acute myeloid leukemia in which leukemic promyelocytes predominate in the bone marrow (BM). Rapid diagnosis is critical for treatment decision since all-trans-retinoic acid must be administrated promptly. The microgranular variant may be of difficult diagnosis, as it may be confused with other diseases on morphological grounds. The purpose of this study was to determine if the microgranular variant has the same antigenic profile as the classical hypergranular type. The immunophenotype of leukemic cells from the bone marrow of 50 patients, with the PML-RARalpha gene rearrangement confirmed by RT-PCR, was determined by flow cytometry using a large panel of 22 monoclonal antibodies and a polyclonal anti-TdT antibody. Thirty-four cases were classified as classical APL and 16 as microgranular APL. The immunophenotypic profile of the two subtypes was indistinguishable concerning the presence or absence of these antigens, including the absence of reactivity for the HLA-DR antigen. The simultaneous immunophenotypic combination of a unique major cell population, heterogeneous intensity of expression of CD13, and the typical pattern of CD15/CD34 expression were similarly present in the hypergranular and microgranular subtypes. Homogeneous expression of CD33 was observed in 76% of the classical APL cases and in 100% of the microgranular cases. Additionally, we have studied two cases of PLZF-RARalpha APL that also displayed the same immunophenotype described for classical APL. Thus, the immunophenotypic profile highly characteristic of the PML-RARalpha gene rearrangement was also observed in microgranular and PLZF-RARalpha variants of APL.


Assuntos
Antígenos CD/biossíntese , Rearranjo Gênico , Leucemia Promielocítica Aguda/diagnóstico , Proteínas de Neoplasias/genética , Proteínas de Fusão Oncogênica/genética , Translocação Genética , Adolescente , Adulto , Idoso , Antígenos CD34/biossíntese , Medula Óssea/imunologia , Medula Óssea/metabolismo , Antígenos CD13/biossíntese , Criança , Análise Citogenética , Feminino , Citometria de Fluxo , Humanos , Imunofenotipagem , Leucemia Promielocítica Aguda/genética , Leucemia Promielocítica Aguda/imunologia , Antígenos CD15/biossíntese , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase Via Transcriptase Reversa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA